Ticker: OCUP

Company: Ocuphire Pharma, Inc.

Person: Foundation Fighting Blindness Retinal Degeneration Fund, director

Transaction date: Dec. 9, 2025

Reporting date: Dec. 11, 2025

Average share price: 2.15

Sold 4000000.0 shares for 8600000.0